🔗 Share this article

Grammy-winning soul vocalist D’Angelo died on October 14 at age 51 after a personal fight with pancreatic cancer.

“The brilliant light of our family has faded away for us in this life,” his family confirmed. “After a lengthy and brave battle with the disease, we are heartbroken to declare that Michael D’Angelo Archer, known to his fans around the world as D’Angelo, has been called home.”

D’Angelo left an indelible mark on the music industry with his pioneering modern soul style and collaborations with high-profile artists.

He released his debut album, “Brown Sugar,” in 1995 to instant praise. The record achieved No. 4 on Billboard’s Top R&B Albums chart, earned platinum status soon after, and received several award nominations.

However, it was his second album, “Voodoo,” in the year 2000 that boosted his artistic journey into the limelight. The record premiered at the top spot on each of Billboard’s Top R&B Albums chart and the main album chart. He received two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” cemented D’Angelo’s reputation as a icon, albeit a hesitant one, in the cultural zeitgeist. The personal depiction featured the artist, famously bare to his midsection, performing directly into the lens.

D’Angelo stepped back from the public eye after releasing Voodoo and openly battled with drugs and alcohol. In 2005, he was part of a severe car crash that left him in critical condition.

Over ten years later, his third and final album, “Black Messiah” (2014), reaffirmed his enduring appeal with a further top chart entry on the R&B chart and a Grammy for Top R&B Record.

Once more, in his own enigmatic way, D’Angelo had limited public appearances in the following years.

The singer was announced as a headliner for the 2025 music event, but his performance was called off, citing an “unforeseen medical delay.”

Even though details are sparse about D’Angelo’s well-being in the weeks before his death, he had apparently been in the hospital for months and in hospice for two weeks.

D’Angelo’s demise is a stark reminder of the devastating effects of pancreatic malignancy, one of the most deadly and least preventable types of the disease, on a gifted artist whose life was cut short.

“We are saddened that he can only leave dear memories with his family, but we are eternally grateful for the heritage of deeply emotional songs he has left us,” his kin expressed.

Pancreatic Malignancy: Deadly and Rarely Preventable

Pancreatic malignancy impacts the digestive organ, a tiny gland that produces the hormone insulin and plays an essential role in breaking down food, among other functions. The position and dimensions of the pancreas in the body make it more difficult to detect cancer.

Although pancreatic cancer accounts for only approximately three percent of cancer diagnoses each year in the U.S., it is causes seven percent of cancer deaths.

Nearly 70,000 people will be found to have pancreatic cancer and roughly fifty-two thousand will succumb to the disease in the year 2025.

“This malignancy is one of the most lethal diseases, with an fast-growing mass and dismal outcomes. We have limited and ineffective therapies, and a smaller window to make a significant difference on the lives of patients,” said a medical oncologist.

Since this disease rarely causes initial signs, it’s often diagnosed only once the disease is advanced. Even when a patient has indicators they are often nonspecific and may be mistaken for a several everyday ailments.

“Currently, there is no good way to identify pancreatic cancer in the initial phases, apart from listening to your body and speaking with your doctor if there are unfamiliar symptoms,” explained a medical director.

Common symptoms of this disease encompass:

• abdominal or lower back pain
• weight loss
• jaundice
• loss of appetite
• dark urine
• pale or fatty bowel movements
• loose stools
• excessive hunger or thirst
• feeling sick

At 51 years old, D’Angelo’s demise is an outlier, as this malignancy is typically found in individuals in the sixty-five to seventy-five age bracket. However, many cancers, including this type, have become more common in younger adults.

“Pancreatic cancer identified prior to fifty is considered uncommon, yet concerningly, doctors are noticing a growing number of younger individuals suffering from this condition,” commented a expert.

Family History Impacts Disease Probability

Without effective screening tools for this malignancy, experts stressed the importance of understanding your family’s health background. Certain contributing elements, such as smoking and obesity also have an influence in the onset of this disease.

Black individuals have the greatest occurrence of this malignancy in the U.S. and are most likely to be diagnosed with untreatable disease.

“The first step toward lowering one’s chance of this condition is assessing personal risk factors. Individuals should review their family history, genetic background, and health issues, such as diabetes, long-term pancreas inflammation, or obesity that may raise their susceptibility,” said a medical professional.

Hereditary risk factors are linked to as much as ten percent of all this malignancy cases. If someone in your family has had this disease, you may want to think about DNA analysis.

“For individuals with a family history of this condition or those carrying high risk DNA changes, checking may involve advanced imaging such as MRI scans or internal ultrasound to detect initial alterations in the organ,” he clarified.

For those looking to reduce their risk, habit adjustments may make a difference. The most effective step you can take to lower your risk of pancreatic cancer is to quit smoking, and if you are a non-smoker, avoid exposure altogether.

Heavy alcohol consumption is linked to pancreas inflammation, a contributing element for this malignancy, so limiting or abstaining from drinks may assist reduce your risk.

Controlling your weight or shedding pounds may also aid decrease your susceptibility. People with obesity are 20% more likely to develop pancreatic cancer. Pancreatic cancer also occurs more often in people with blood sugar issues, and weight loss can also reduce the risk of type 2 diabetes.

In spite of pancreatic cancer’s grim outlook, there is still hope.

“We are making progress with therapies and newer combination chemotherapy. There are developing targeted therapies that are already showing results,” said a specialist.

For numerous people, however, awareness about this uncommon but {dev